In many parts of the world, probiotics are subject to different manufacturing and quality control standards than pharmaceuticals. Could these different standards have any implications for patient health? Mary Ellen Sanders and colleagues recently wrote a commentary in the Journal of the American Pharmacists Association on probiotic use in at-risk populations. In the paper, they explained that health care providers…
In many parts of the world, probiotics are subject to different manufacturing and quality control standards than pharmaceuticals. Could these different standards have any implications for patient health? Mary Ellen Sanders and colleagues recently wrote a commentary in the Journal of the American Pharmacists Association on probiotic use in at-risk populations. In the paper, they explained that health care providers…
